Details of Drug

Details of Drug

 Drug General Information (ID: D0090)
  Drug Name
Antihemophilic factor, human recombinant
  Drug Type Protein/peptide
  Drug Synonymous
Antihemophilic factor (recombinant); Antihemophilic factor recombinant; Antihemophilic factor, human recombinant; Antihemophilic factor, recombinant; DB00025; Factor VIII (rDNA); Factor VIII (Recombinant); Factor VIII recombinFactor VIII, recombinantHuman Factor VIII (Recombinant)Human factor VIII recombinantOctocog alfarAHFRecombinant antihemophilic factor VIII
    Click to Show/Hide
  Therapeutic Class Recombinant Coagulation Factor Viii

Drug-Drug Interaction Network
  Sunburst Graph
AM006  Pharmacodynamic additive effects
BM047  Additive thrombogenic effects
BM048  Increased risk of angioedema/anaphylactoid reactions
  Relation Graph
 Full list of drugs interacting with Antihemophilic factor, human recombinant
      Pharmacodynamic additive effects
   Additive thrombogenic effects Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0261
 
Carfilzomib
 
C40H57N5O7
 
11556711 
Major    Inter Info   
[1], [2], [3]
   Increased risk of angioedema/anaphylactoid reactions Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1861
 
Pegvaliase
 
C15H30N2O5
 
86278362 
Moderate    Inter Info   
[4]
References
1 Product Information. Kyprolis (carfilzomib). Onyx Pharmaceuticals Inc, South San Francisco, CA.
2 Cerner Multum, Inc. "Australian Product Information.".
3 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
4 Product Information. Palynziq (pegvaliase). BioMarin Pharmaceutical Inc, Novato, CA.